TOP STORIES

• BUSINESS Predictability Key to Novartis’ Japan Investment, Says International Chief
  September 16, 2025

• BUSINESS LEO Pharma Reinforces Japan Push toward Dermatology Leadership
  September 12, 2025

• BUSINESS Sawai and T’s Pharma Won Forxiga Generics by Skirting Patent, Will the Strategy Hold?
  September 11, 2025

• REGULATORY Reblozyl Faces Price Cut after Cost-Effectiveness Assessment
  September 11, 2025

• BUSINESS Teijin Pharma Bets on Ascendis Rare Disease Assets as Feburic Sales Crumble
  September 10, 2025

• BUSINESS Amicus CEO Confident on US$1 Billion Sales Target as Japan Pompe Launch Gets Underway
  September 9, 2025

• BUSINESS KM Biologics Developing Higher-Yield Liquid Immunoglobulin to Boost Efficiency and Supply
  September 8, 2025

• ORGANIZATION JPMA Code & Compliance Chair Stresses Need to Embed Spirit of Revised COP
  September 8, 2025

• COMMENTARY MHLW Grows Jittery over Supply Risks amid Rising Foreign Investments
  September 8, 2025

• BUSINESS And Pharma Chief Pledges Growth Strategy as New Generics Holding Firm Takes Shape
  September 5, 2025

• ORGANIZATION JPMA ICH Project Chair Sees RWE as Potential Complement to Clinical Trials
  September 5, 2025

• BUSINESS Bayer Pushes Cross-Border Open Innovation with New Co.Lab Connect Program
  September 4, 2025

• ORGANIZATION JPMA Regulatory Chief Seeks Balanced Approach on Japanese PI Waivers
  September 3, 2025

• REGULATORY Pharma Groups Press Pricing Reform at First Public-Private WG Meeting
  September 2, 2025

• REGULATORY Japan Panel Clears Izervay, Nexletol for Approval; Eylea Biosimilars Edge Ahead Too
  September 1, 2025

• REGULATORY METI Proposes “Bold Investment” Tax Breaks in FY2026 Request
  September 1, 2025

• REGULATORY Japan Panel Green Lights Nonprescription Switch of Morning-After Pill
  September 1, 2025

• REGULATORY MHLW Orders Label Revision for Elevidys to Add Acute Hepatic Failure
  September 1, 2025

• ORGANIZATION Indicators Needed to Frame Pharma as Growth Market in Japan, Says JPMA Policy Chief
  August 29, 2025

• REGULATORY Japan to Expand List of “Stable Supply Medicines” to 759 APIs, Adding Vaccines and Blood Products
  August 28, 2025

ページ

• « 先頭
• ‹ Prev
• …
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• …
• Next ›
• 最終 »